Advertisement

Journal of Cancer Research and Clinical Oncology

, Volume 141, Issue 8, pp 1353–1361 | Cite as

Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer

  • Zhiqiang Wang
  • Ming Cai
  • Yuan Weng
  • Fang Zhang
  • Dong Meng
  • Jun Song
  • Huan Zhou
  • Zongtao XieEmail author
Original Article – Cancer Research

Abstract

Purpose

Metastasis-associated in colon cancer-1 (MACC1) is a newly identified gene that plays an important role in cancer progression and metastasis. MACC1 has important functions in the differentiation, invasion, and metastasis of nonsmall cell lung cancer (NSCLC). However, the value of circulating MACC1 as a potential diagnostic and prognostic biomarker for NSCLC remains unknown.

Methods

Plasma MACC1 mRNA levels were examined in 272 patients with NSCLC, 61 with benign lung disease, and 80 healthy volunteers using reverse transcription quantitative real-time polymerase chain reaction.

Results

MACC1 was more highly expressed in NSCLC patients than in patients with benign disease (P < 0.001) or in healthy volunteers (P < 0.001). High MACC1 expression was significantly associated with NSCLC stage (P = 0.013) and lymph node metastasis (P = 0.016). The area under the receiver operating characteristic curve was 0.766, and the optimal cutoff value was 0.105, providing a sensitivity of 71.4 % and a specificity of 89.1 %. The diagnostic capability of circulating MACC1 mRNA was higher than that of carcinoembryonic antigen (P = 0.025) or cytokeratin-19 (P = 0.010). Furthermore, high MACC1 expression was associated with poor overall survival (OS) and disease-free survival (DFS) and predicted poor survival in NSCLC patients. Consequently, MACC1 mRNA was an independent prognostic factor of OS and DFS.

Conclusion

We concluded that circulating MACC1 mRNA represents a potential noninvasive, diagnostic and prognostic marker for NSCLC.

Keywords

Circulating MACC1 mRNA Nonsmall cell lung cancer Diagnosis Prognosis Plasma 

Notes

Acknowledgments

We would like to thank Yonggong Wang, Yang Xia, and Jiajie Hou from Nanjing Medical University for technical assistance.

Conflict of interest

We declare that we have no conflict of interest.

References

  1. Alberg AJ, Ford JG, Samet JM, American College of Chest P (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:29S–55S. doi: 10.1378/chest.07-1347 PubMedCrossRefGoogle Scholar
  2. Arlt F, Stein U (2009) Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41:2356–2359. doi: 10.1016/j.biocel.2009.08.001 PubMedCrossRefGoogle Scholar
  3. Arya SK, Bhansali S (2011) Lung cancer and its early detection using biomarker-based biosensors. Chem Rev 111:6783–6809. doi: 10.1021/cr100420s PubMedCrossRefGoogle Scholar
  4. Boardman LA (2009) Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1:36. doi: 10.1186/gm36 PubMedPubMedCentralCrossRefGoogle Scholar
  5. Cabrera-Alarcon JL, Carrillo-Vico A, Santotoribio JD, Leon-Justel A, Sanchez-Gil R, Gonzalez-Castro A, Guerrero JM (2011) CYFRA 21-1 as a tool for distant metastasis detection in lung cancer. Clin Lab 57:1011–1014PubMedGoogle Scholar
  6. Cho JY, Sung HJ (2009) Proteomic approaches in lung cancer biomarker development. Expert Rev Proteomics 6:27–42. doi: 10.1586/14789450.6.1.27 PubMedCrossRefGoogle Scholar
  7. Chundong G et al (2011) Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 31:1141–1145PubMedGoogle Scholar
  8. Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C, Jandrig B (2001) Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci 945:179–188PubMedCrossRefGoogle Scholar
  9. Gahan PB (2010) Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J 1:503–512. doi: 10.1007/s13167-010-0021-6 PubMedPubMedCentralCrossRefGoogle Scholar
  10. Gridelli C, Rossi A, Maione P (2011) 2010 Consensus on lung cancer, new clinical recommendations and current status of biomarker assessment—first-line therapy. Eur J Cancer 47(Suppl 3):s248–s257. doi: 10.1016/S0959-8049(11)70171-X PubMedCrossRefGoogle Scholar
  11. Guo T, Yang J, Yao J, Zhang Y, Da M, Duan Y (2013) Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int 13:121. doi: 10.1186/1475-2867-13-121 PubMedPubMedCentralCrossRefGoogle Scholar
  12. Hagemann C et al (2013) Impact of MACC1 on human malignant glioma progression and patients’ unfavorable prognosis. Neurooncol 15:1696–1709. doi: 10.1093/neuonc/not136 Google Scholar
  13. Holdenrieder S, Nagel D, Stieber P (2010) Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer. Cancer Biomark 6:179–190. doi: 10.3233/CBM-2009-0128 PubMedGoogle Scholar
  14. Hu X, Fu X, Wen S, Zou X, Liu Y (2012) Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer. Chin J Lung Cancer 15:399–403. doi: 10.3779/j.issn.1009-3419.2012.07.02 Google Scholar
  15. Huang J, Wang K, Xu J, Huang J, Zhang T (2013a) Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis. PloS One 8:e78070. doi: 10.1371/journal.pone.0078070 PubMedPubMedCentralCrossRefGoogle Scholar
  16. Huang Y et al (2013b) Overexpression of MACC1 and its significance in human. Breast Cancer Progress Cell Biosci 3:16. doi: 10.1186/2045-3701-3-16 Google Scholar
  17. Isella C et al (2013) MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg 257:1089–1095. doi: 10.1097/SLA.0b013e31828f96bc PubMedCrossRefGoogle Scholar
  18. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi: 10.3322/caac.20107 PubMedCrossRefGoogle Scholar
  19. Kawamura M et al (2012) Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res 32:1527–1531PubMedGoogle Scholar
  20. Kokoszynska K, Krynski J, Rychlewski L, Wyrwicz LS (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56:317–323PubMedGoogle Scholar
  21. Kopreski MS, Benko FA, Kwak LW, Gocke CD (1999) Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5:1961–1965PubMedGoogle Scholar
  22. Lo KW et al (1999) Analysis of cell-free Epstein-barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 45:1292–1294PubMedGoogle Scholar
  23. Meng F et al (2013) MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One 8:e60821. doi: 10.1371/journal.pone.0060821 PubMedPubMedCentralCrossRefGoogle Scholar
  24. Muinelo-Romay L et al (2014) Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment. Cancers 6:153–165. doi: 10.3390/cancers6010153 PubMedPubMedCentralCrossRefGoogle Scholar
  25. Qiu J et al (2011) Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9:166. doi: 10.1186/1479-5876-9-166 PubMedPubMedCentralCrossRefGoogle Scholar
  26. Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T, Yasumoto K (2011) Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 141:895–898. doi: 10.1016/j.jtcvs.2010.09.044 PubMedCrossRefGoogle Scholar
  27. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236. doi: 10.3322/caac.20121 PubMedCrossRefGoogle Scholar
  28. Stein U et al (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15:59–67. doi: 10.1038/nm.1889 PubMedCrossRefGoogle Scholar
  29. Stein U, Dahlmann M, Walther W (2010) MACC1—more than metastasis? Facts and predictions about a novel gene. J Mol Med 88:11–18. doi: 10.1007/s00109-009-0537-1 PubMedCrossRefGoogle Scholar
  30. Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, Schlag PM (2011) Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients. J Mol Diagn 13:189–198. doi: 10.1016/j.jmoldx.2010.10.002 PubMedPubMedCentralCrossRefGoogle Scholar
  31. Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, Schlag PM (2012) Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One 7:e49249. doi: 10.1371/journal.pone.0049249 PubMedPubMedCentralCrossRefGoogle Scholar
  32. Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y (2011) Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 137:1151–1173. doi: 10.1007/s00432-011-0988-y PubMedCrossRefGoogle Scholar
  33. Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL (2012) MACC1: a potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett 4:783–791. doi: 10.3892/ol.2012.784 PubMedPubMedCentralGoogle Scholar
  34. Wang L et al (2013) Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer 133:1419–1430. doi: 10.1002/ijc.28140 PubMedCrossRefGoogle Scholar
  35. Wang Z et al (2014) MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol 31:790. doi: 10.1007/s12032-013-0790-6 PubMedCrossRefGoogle Scholar
  36. Xie C et al (2013) MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 8:e64235. doi: 10.1371/journal.pone.0064235 PubMedPubMedCentralCrossRefGoogle Scholar
  37. Yang T et al (2013) Overexpression of MACC1 protein and its clinical implications in patients with glioma. Tumour Biol. doi: 10.1007/s13277-013-1112-5 PubMedCentralGoogle Scholar
  38. Zhang RT, Shi HR, Huang HL, Chen ZM, Liu HN, Yuan ZF (2011) Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance. J South Med Univ 31:1551–1555Google Scholar
  39. Zhang X et al (2012) Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer 131:165–172. doi: 10.1002/ijc.26360 PubMedCrossRefGoogle Scholar
  40. Zhang K et al (2013a) MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol. doi: 10.1007/s13277-013-1335-5 Google Scholar
  41. Zhang K, Zhang Y, Zhu H, Xue N, Liu J, Shan C, Zhu Q (2013b) High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumour Biol. doi: 10.1007/s13277-013-1180-6 Google Scholar
  42. Zhu M, Xu Y, Mao X, Gao Y, Shao L, Yan F (2013) Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res 19:749–753. doi: 10.1007/s12253-013-9638-9 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Zhiqiang Wang
    • 1
  • Ming Cai
    • 1
  • Yuan Weng
    • 1
  • Fang Zhang
    • 2
  • Dong Meng
    • 3
  • Jun Song
    • 4
  • Huan Zhou
    • 5
  • Zongtao Xie
    • 1
    Email author
  1. 1.Department of Thoracic and Cardiovascular Surgery, Affiliated Hospital of Jiangnan UniversityThe Forth People’s Hospital of Wuxi CityWuxiChina
  2. 2.Department of Respiratory Medicine, Affiliated Hospital of Jiangnan UniversityThe Forth People’s Hospital of Wuxi CityWuxiChina
  3. 3.Department of Breast Oncology Center, Affiliated Hospital of Jiangnan UniversityThe Forth People’s Hospital of Wuxi CityWuxiChina
  4. 4.Department of Dermatology, Affiliated Hospital of Jiangnan UniversityThe Forth People’s Hospital of Wuxi CityWuxiChina
  5. 5.Department of Clinical Laboratory, Affiliated Hospital of Jiangnan UniversityThe Forth People’s Hospital of Wuxi CityWuxiChina

Personalised recommendations